Literature DB >> 21835750

An integrated system for disaster preparedness and response.

Dale L Thompson1.   

Abstract

Kaiser Permanente, the USA's largest not-for-profit integrated healthcare provider, has developed a hybrid emergency preparedness and response system. It consists of a tiered structure of national 'workgroups' and traditional physical command centre operations. The workgroups provide integration and coordination across a large organisation while allowing for necessary regional operational flexibility. Workgroup membership taps the best available expertise in a functional area, drawn from all levels and all regions, so as to best represent all interests of a divergent, widespread organisation. Workgroups exist in 'standby' until a threat emerges, then are activated as needed, excepting the core clinical workgroup which meets at least monthly to track potential risks to the organisation. These workgroups promote internal consistency, represent the organisation to outside entities, and develop tools, templates and protocols that regions can adapt, adopt and implement through a traditional, operational system of regional and medical centre and clinical emergency command centres. Developed in response to the anthrax terrorism in the early 1990s, this hybrid system allowed for a rapidly escalated, yet measured response to the recent H1N1 outbreak and could be a template for application in other organisations with similar needs.

Entities:  

Mesh:

Year:  2011        PMID: 21835750

Source DB:  PubMed          Journal:  J Bus Contin Emer Plan        ISSN: 1749-9216


  1 in total

Review 1.  Engagement and education: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.

Authors:  Asha V Devereaux; Pritish K Tosh; John L Hick; Dan Hanfling; James Geiling; Mary Jane Reed; Timothy M Uyeki; Umair A Shah; Daniel B Fagbuyi; Peter Skippen; Jeffrey R Dichter; Niranjan Kissoon; Michael D Christian; Jeffrey S Upperman
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.